Patent ID: 11904081
Assignee: LUPAGEN, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A

Claim 0:
1. A subject-connected, closed-loop system for the modification of a cell, the system comprising:
a) an inlet conduit adapted for parenteral communication with the subject and adapted for receiving blood from the subject;
b) a cell separation module in fluid communication with the inlet conduit, the cell separation module comprising a cell separator configured to produce a fraction enriched in a target nucleated blood cell type using the blood from the subject, and the cell separation module further comprising a first sampling unit for obtaining a sample of the fraction;
c) a cell customization module in fluid communication with the cell separation module so as to receive the nucleated blood cell fraction enriched in the target cell type from the cell separation module, the cell customization module configured to present one or more modifying agents to the target nucleated blood cells, thereby generating modified cells, and the cell customization module further comprising a second sampling unit for obtaining a sample of the modified cells, wherein the cell customization module comprises a conduit that permits a first batch of target cells treated with a modifying agent to pass into a temperature-controlled holding unit while a second batch is treated with modifying agent;
d) a detector configured to conduct a detection operation and operably interfaced with the cell separation module, the cell customization module, operably interfaced between the cell separation module and the cell customization module, and/or operably interfaced between the cell customization module or the cell separation module and the subject;
e) an outlet conduit adapted for parenteral communication with the subject and for conducting modified target cells parenterally to the subject; and
f) a processor configured to control an operation of the inlet conduit, the cell separation module, the cell customization module, the detector, or the outlet conduit of the system;
wherein the inlet conduit, the cell separation module, the cell customization module, the detector, and the outlet conduit of the system are connected in a fluid-sealed closed-loop adapted for parenteral connection with a patient at both ends of the fluid sealed closed-loop, and the system is configured to permit cell separation, delivery of a modifying agent to the target nucleated blood cell type and delivery of the modified cells to the subject in real time within the fluid sealed closed-loop.